News
vMap Surpasses 2,000 Procedures, Marking a New Era in Arrhythmia Care
Vektor Medical announced today that vMap has been used in over 2,000 procedures across more than 20 U.S. hospitals - a milestone reflecting growing clinical demand for non-invasive, AI-driven arrhythmia mapping.
vMap localizes both focal and fibrillation-type arrhythmias using a standard 12-lead ECG, delivering actionable insights in under a minute. Clinical studies have shown it’s associated with reduced procedure time, offering potential improvements in safety and efficiency.
“vMap has become integral to how I treat patients,” said Dr. Anish Amin, Section Chief, Electrophysiology, OhioHealth. “It helps me identify arrhythmia sources quickly and confidently - supporting more effective, targeted ablation.”
As adoption of pulsed field ablation (PFA) grows, vMap is increasingly valued for helping identify ablation targets before and during procedures. The announcement comes as enrollment begins in the IMPRoVED-AF study, a randomized trial evaluating vMap in persistent and recurrent AF.
